 MINNEAPOLIS, March 26, 2021 GLOBE NEWSWIRE -- Panbela Therapeutics, Inc. Nasdaq: PBLA, is re-issuing this press release solely to correct an inadvertent decimal error in the net loss per share reported in the discussion under the heading Fourth Quarter ended December 31, 2020 Financial Results. All other data and disclosure remains unchanged. 